
Over a three-month period, contributed to the opentargets/gentropy repository by developing four features focused on data quality and interpretability in genomics workflows. Built a targeted quality control check for Posterior Inclusion Probabilities, ensuring numerical reliability in credibility set analysis using Python and PySpark. Enhanced colocalisation analysis by incorporating beta ratio sign computation and improved eQTL Catalogue classification to distinguish single-cell from bulk datasets, supporting more accurate downstream analysis. Further strengthened biosample data representation by adding parent and child relationship extraction, improving data completeness. Demonstrated expertise in bioinformatics, data validation, and ETL, with a focus on maintainable, auditable code delivery.
November 2025 performance summary: delivered Biosample Relationship Extraction Enhancement in opentargets/gentropy by introducing parent/child predicates to the biosample index, improving accuracy and completeness of biosample data representation. This work strengthens data curation, enables more reliable downstream analytics, and supports better biological relationship mapping.
November 2025 performance summary: delivered Biosample Relationship Extraction Enhancement in opentargets/gentropy by introducing parent/child predicates to the biosample index, improving accuracy and completeness of biosample data representation. This work strengthens data curation, enables more reliable downstream analytics, and supports better biological relationship mapping.
November 2024 highlights for opentargets/gentropy focused on delivering features that boost interpretability and data quality. Delivered Colocalisation beta ratio sign inclusion and enhanced eQTL Catalogue dataset classification, enabling directional interpretation of colocalisation signals and more accurate single-cell vs bulk labeling. These changes improve downstream analyses, reduce mislabeled data, and support better prioritization of causal signals. Demonstrated strengths in data integration, algorithm extension, and classification refinement, with clear commit traceability for future audits and collaboration.
November 2024 highlights for opentargets/gentropy focused on delivering features that boost interpretability and data quality. Delivered Colocalisation beta ratio sign inclusion and enhanced eQTL Catalogue dataset classification, enabling directional interpretation of colocalisation signals and more accurate single-cell vs bulk labeling. These changes improve downstream analyses, reduce mislabeled data, and support better prioritization of causal signals. Demonstrated strengths in data integration, algorithm extension, and classification refinement, with clear commit traceability for future audits and collaboration.
Monthly summary for 2024-10: Implemented a targeted quality control feature in opentargets/gentropy to improve credibility set analysis reliability. The Quality Control Check flags study loci with abnormal sums of Posterior Inclusion Probabilities (PIPs) and filters results to enforce sums in the 0.99–1.00 range, accommodating floating-point inaccuracy. This enhances data quality, trust, and reproducibility for downstream genetic inferences. Tech highlights include Python-based data quality checks, handling floating-point tolerance, Git-based delivery, code review, and CI-aligned testing. Business value: reduces false positives due to numerical imprecision and strengthens the reliability of gene-trait mappings.
Monthly summary for 2024-10: Implemented a targeted quality control feature in opentargets/gentropy to improve credibility set analysis reliability. The Quality Control Check flags study loci with abnormal sums of Posterior Inclusion Probabilities (PIPs) and filters results to enforce sums in the 0.99–1.00 range, accommodating floating-point inaccuracy. This enhances data quality, trust, and reproducibility for downstream genetic inferences. Tech highlights include Python-based data quality checks, handling floating-point tolerance, Git-based delivery, code review, and CI-aligned testing. Business value: reduces false positives due to numerical imprecision and strengthens the reliability of gene-trait mappings.

Overview of all repositories you've contributed to across your timeline